Back to RA CAPITAL MANAGEMENT, L.P.

DNTH
Showing 8 of 9 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in DIANTHUS THERAPEUTICS INC

RA CAPITAL MANAGEMENT, L.P. holds 2.6M shares of DNTH (DIANTHUS THERAPEUTICS INC), worth $219.2M as of 2026-Q1. The position was increased (+62.0% shares). DNTH represents 2.3% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$219.2M

Current Shares

2.6M

Total Value Change

+$158.8M

Total Shares Change

+278,733

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.6M
+62.0%
$219.2M2.3%$55.39
76
2025-Q4
Decreased
1.6M
-43.8%
$66.4M0.7%$40.96
0
2025-Q3
Unchanged
2.9M
0.0%
$112.8M1.4%$39.55
0
2025-Q2
Unchanged
2.9M
0.0%
$53.4M0.9%$17.63
0
2025-Q1
Increased
2.9M
+53.6%
$52M0.9%$19.99
58
2024-Q4
Decreased
1.9M
-20.0%
$40.7M0.5%$21.50
0
2024-Q3
Unchanged
2.3M
0.0%
$63.9M0.7%$27.24
0
2024-Q2
Unchanged
2.3M
0.0%
$60.4M0.8%$25.88
0

Other major holders of DNTH: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used